Showing results (1-10 of 151) with videos related to
Sort By:
Pageof 16
Current Drug Targets|February 16, 2006
Pindolol augmentation of antidepressant responseFrancesc Artigas, Albert Adell, Pau CeladaBrain Research. Brain Research Reviews|November 9, 2002
Origin and functional role of the extracellular serotonin in the midbrain raphe nucleiAlbert Adell, Pau Celada, M Teresa Abellán, et al.Journal of Psychiatry & Neuroscience : JPN|August 17, 2004
The therapeutic role of 5-HT1A and 5-HT2A receptors in depressionPau Celada, M Puig, Mercè Amargós-Bosch, et al.Drug Discovery Today|April 20, 2005
Strategies for producing faster acting antidepressantsAlbert Adell, Elena Castro, Pau Celada, et al.Neuroscience and Biobehavioral Reviews|August 4, 2004
The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systemsAlbert Adell, Francesc ArtigasEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 28, 2017
Can we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategiesFrancesc Artigas, Analia Bortolozzi, Pau CeladaCNS Drugs|June 13, 2013
Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of researchPau Celada, Analía Bortolozzi, Francesc ArtigasCurrent Pharmaceutical Design|November 5, 2013
Novel therapeutic strategies in major depression: focus on RNAi and ketamineAnalia Bortolozzi, Pau Celada, Francesc ArtigasFrontiers in Integrative Neuroscience|April 30, 2013
Serotonin modulation of cortical neurons and networksPau Celada, M Victoria Puig, Francesc ArtigasCerebral Cortex (New York, N.Y. : 1991)|July 9, 2004
Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABAM Victoria Puig, Francesc Artigas, Pau CeladaPageof 16